Natural Experiment of Value-Based Incentives for Preventive Services
基于价值的预防服务激励的自然实验
基本信息
- 批准号:8883236
- 负责人:
- 金额:$ 65.99万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2012
- 资助国家:美国
- 起止时间:2012-09-24 至 2016-06-30
- 项目状态:已结题
- 来源:
- 关键词:2 year oldAdolescentAdvisory CommitteesAffectAgeAmericanBehaviorBudgetsCaringCenters for Disease Control and Prevention (U.S.)CharacteristicsChickenpoxChildClinicalCost SharingDataData SetDatabasesDiseaseDoseEconomicsEffectivenessEnrollmentEventFaceFutureGoalsGroup Health InsuranceHealth InsuranceHealthcareHuman PapillomavirusImmunizationImprove AccessIncentivesIndividualInpatientsInsuranceInsurance BenefitsLinkLiteratureLong-Term EffectsMedicalMeningococcal vaccineNational Health PolicyNatural experimentOffice VisitsOnly ChildOutcomeOutpatientsPatientsPersonsPertussisPharmaceutical PreparationsPolicePoliciesPopulationPreventionPreventivePriceRoleRotavirusSamplingSampling StudiesSentinelSeriesServicesSystemTestingTimeVaccinesVariantVisitWorkbasecare systemscomparativecostdesigndisorder preventionfinancial incentiveimprovedmembermodels and simulationnovel vaccinespreventtool
项目摘要
DESCRIPTION (provided by applicant): Financial incentives can be powerful tools to influence health care behavior. The literature suggests that patients faced with high levels of cost-sharing have lower use of preventive services than patients with less cost-sharing, but there are few studies in children and only a limited number of studies in any population demonstrating that the elimination of cost-sharing increases use of prevention. This alignment of insurance benefit design with clinical goals, aka value-based insurance design (VBID), is a central feature of the recent Patient Protection and Affordable Care Act (ACA). The ACA requires that all health insurance plans eliminate cost-sharing for high value preventive services including those services recommended by the US Preventive Services Task Force (USPSTF) and the Centers for Disease Control and Prevention (CDC) as of 2011; the ACA, however, exempts existing employer-sponsored (i.e., group) insurance plans from these policies provided that the plans do not make major changes in their benefits or prices. Thus, individuals within these "grandfathered" plans continue to face the same cost-sharing for preventive care. We will exploit this natural experiment to examine how the elimination of cost-sharing for annual wellness visits and immunizations affects children and adolescents (age up to 21 years). Individuals enrolled in group health insurance plans without cost-sharing changes and tests not recommended by the USPSTF provide concurrent comparative information. Using data from the MarketScan Databases and from Kaiser Permanente, the project will examine the early clinical and economic effects of this ACA-mandated health insurance policy change on our outcomes: Aim 1) office visit rates; Aim 2) immunizations; and Aim 3) total medical spending. Our data contain detailed, comprehensive information on insurance benefits, individual characteristics, immunizations, clinical events, and medical spending. The study sample includes subjects with a range of baseline cost-sharing amounts and in the timing of cost-sharing changes. Our primary analyses will focus on within-person changes (fixed effects estimation), and will adjust for a rich set of demographic, clinical, and system characteristics. With several million person-years of data, we will have adequate power to detect even small changes in our outcomes.
描述(由申请人提供):经济激励可以成为影响医疗保健行为的有力工具。文献表明,与费用分摊较少的患者相比,面临高水平费用分摊的患者对预防服务的使用较少,但针对儿童的研究很少,而且在任何人群中的研究也很少,表明取消费用分摊会增加预防的使用。这种保险福利设计与临床目标的结合,又称为基于价值的保险设计 (VBID),是最近《患者保护和平价医疗法案》(ACA) 的核心特征。 ACA 要求所有健康保险计划取消高价值预防服务的费用分摊,包括美国预防服务工作组 (USPSTF) 和疾病控制与预防中心 (CDC) 自 2011 年起推荐的服务;然而,如果现有的雇主赞助(即团体)保险计划的福利或价格没有发生重大变化,《平价医疗法案》将其排除在这些保单之外。因此,这些“祖父”计划中的个人继续面临相同的预防性护理费用分摊。我们将利用这一自然实验来研究取消每年健康检查和免疫接种费用分摊对儿童和青少年(21 岁以下)的影响。加入团体健康保险计划但未进行费用分摊变更的个人以及 USPSTF 未推荐的测试可提供同时的比较信息。该项目将利用 MarketScan 数据库和 Kaiser Permanente 的数据,研究 ACA 规定的健康保险政策变更对我们结果的早期临床和经济影响:目标 1) 办公室就诊率;目标2)免疫接种;目标 3) 医疗支出总额。我们的数据包含有关保险福利、个人特征、免疫接种、临床事件和医疗支出的详细、全面的信息。研究样本包括具有一系列基线成本分摊金额和成本分摊变化时间的受试者。我们的主要分析将侧重于人体内的变化(固定效应估计),并将针对丰富的人口统计、临床和系统特征进行调整。有了数百万人年的数据,我们将有足够的能力来检测结果的微小变化。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JOHN HSU其他文献
JOHN HSU的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JOHN HSU', 18)}}的其他基金
Impact of Medicare Polices on Beneficiaries with ADRD
医疗保险政策对 ADRD 受益人的影响
- 批准号:
10728582 - 财政年份:2023
- 资助金额:
$ 65.99万 - 项目类别:
Impact of the COVID-19 Pandemic on Patients with Alzheimer's Disease and Alzheimer's Disease Related Dementias
COVID-19 大流行对阿尔茨海默病和阿尔茨海默病相关痴呆症患者的影响
- 批准号:
10683255 - 财政年份:2021
- 资助金额:
$ 65.99万 - 项目类别:
Impact of the COVID-19 Pandemic on Patients with Alzheimer's Disease and Alzheimer's Disease Related Dementias
COVID-19 大流行对阿尔茨海默病和阿尔茨海默病相关痴呆症患者的影响
- 批准号:
10423845 - 财政年份:2021
- 资助金额:
$ 65.99万 - 项目类别:
Alzheimer's Disease and Related Dementia Care within the Medicare Program
医疗保险计划内的阿尔茨海默病和相关痴呆症护理
- 批准号:
10413262 - 财政年份:2018
- 资助金额:
$ 65.99万 - 项目类别:
Alzheimer's Disease and Related Dementia Care within the Medicare Program
医疗保险计划内的阿尔茨海默病和相关痴呆症护理
- 批准号:
10221576 - 财政年份:2018
- 资助金额:
$ 65.99万 - 项目类别:
COVID-19 and Acute Medical Care: Impact on Dementia Patients
COVID-19 和紧急医疗护理:对痴呆症患者的影响
- 批准号:
10168228 - 财政年份:2018
- 资助金额:
$ 65.99万 - 项目类别:
Alzheimer's Disease and Related Dementia Care within the Medicare Program
医疗保险计划内的阿尔茨海默病和相关痴呆症护理
- 批准号:
9789181 - 财政年份:2018
- 资助金额:
$ 65.99万 - 项目类别:
To Screen or Not To Screen: Prevention Decisions and Competing Risks
筛查或不筛查:预防决策和竞争风险
- 批准号:
8727778 - 财政年份:2014
- 资助金额:
$ 65.99万 - 项目类别:
Fixed Dose Intervention Trial of New England Enhancing Survival in SMI Patients
新英格兰提高 SMI 患者生存率的固定剂量干预试验
- 批准号:
8919458 - 财政年份:2014
- 资助金额:
$ 65.99万 - 项目类别:
Screening for Free: A Value-Based Insurance Design Natural Experiment
免费筛选:基于价值的保险设计自然实验
- 批准号:
8913062 - 财政年份:2012
- 资助金额:
$ 65.99万 - 项目类别:
相似海外基金
Exploring the mental health and wellbeing of adolescent parent families affected by HIV in South Africa
探讨南非受艾滋病毒影响的青少年父母家庭的心理健康和福祉
- 批准号:
ES/Y00860X/1 - 财政年份:2024
- 资助金额:
$ 65.99万 - 项目类别:
Fellowship
Scaling-up co-designed adolescent mental health interventions
扩大共同设计的青少年心理健康干预措施
- 批准号:
MR/Y020286/1 - 财政年份:2024
- 资助金额:
$ 65.99万 - 项目类别:
Fellowship
Shared Spaces: The How, When, and Why of Adolescent Intergroup Interactions
共享空间:青少年群体间互动的方式、时间和原因
- 批准号:
ES/T014709/2 - 财政年份:2024
- 资助金额:
$ 65.99万 - 项目类别:
Research Grant
Social Media Mechanisms Affecting Adolescent Mental Health (SoMe3)
影响青少年心理健康的社交媒体机制 (SoMe3)
- 批准号:
MR/X034925/1 - 财政年份:2024
- 资助金额:
$ 65.99万 - 项目类别:
Fellowship
Parent-adolescent informant discrepancies: Predicting suicide risk and treatment outcomes
父母与青少年信息差异:预测自杀风险和治疗结果
- 批准号:
10751263 - 财政年份:2024
- 资助金额:
$ 65.99万 - 项目类别:
Adolescent sugar overconsumption programs food choices via altered dopamine signalling
青少年糖过度消费通过改变多巴胺信号来影响食物选择
- 批准号:
BB/Y006496/1 - 财政年份:2024
- 资助金额:
$ 65.99万 - 项目类别:
Research Grant
The Impact of Online Social Interactions on Adolescent Cognition
在线社交互动对青少年认知的影响
- 批准号:
DE240101039 - 财政年份:2024
- 资助金额:
$ 65.99万 - 项目类别:
Discovery Early Career Researcher Award
Resilience Factors, Pain, and Physical Activity in Adolescent Chronic Musculoskeletal Pain
青少年慢性肌肉骨骼疼痛的弹性因素、疼痛和体力活动
- 批准号:
10984668 - 财政年份:2024
- 资助金额:
$ 65.99万 - 项目类别:
Augmented Social Play (ASP): smartphone-enabled group psychotherapeutic interventions that boost adolescent mental health by supporting real-world connection and sense of belonging
增强社交游戏 (ASP):智能手机支持的团体心理治疗干预措施,通过支持现实世界的联系和归属感来促进青少年心理健康
- 批准号:
10077933 - 财政年份:2023
- 资助金额:
$ 65.99万 - 项目类别:
EU-Funded
Family-Focused Adolescent & Lifelong Health Promotion (FLOURISH)
以家庭为中心的青少年
- 批准号:
10050850 - 财政年份:2023
- 资助金额:
$ 65.99万 - 项目类别:
EU-Funded














{{item.name}}会员




